The University of Chicago Header Logo

Connection

John Edward A. Blair to Stroke Volume

This is a "connection" page, showing publications John Edward A. Blair has written about Stroke Volume.
Connection Strength

3.033
  1. Coronary Microvascular Dysfunction and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. J Card Fail. 2019 10; 25(10):843-845.
    View in: PubMed
    Score: 0.586
  2. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2018 05 01; 314(5):H1033-H1042.
    View in: PubMed
    Score: 0.526
  3. Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report. ESC Heart Fail. 2017 11; 4(4):645-648.
    View in: PubMed
    Score: 0.503
  4. Diastolic Function and Transcatheter Aortic Valve Replacement. J Am Soc Echocardiogr. 2017 Jun; 30(6):541-551.
    View in: PubMed
    Score: 0.494
  5. Heart Failure With Preserved Ejection Fraction: Have We Finally Found the Perfect Noninvasive Biomarker? Circ Cardiovasc Imaging. 2016 12; 9(12).
    View in: PubMed
    Score: 0.484
  6. Left Ventricular Pressure Ratio Predicts In-Hospital Outcomes in Hospitalized Heart Failure With Reduced Ejection Fraction. J Invasive Cardiol. 2021 Jul; 33(7):E507-E515.
    View in: PubMed
    Score: 0.166
  7. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J. 2011 Oct; 32(20):2563-72.
    View in: PubMed
    Score: 0.083
  8. Radial artery pulse pressure variation correlates with brachial artery peak velocity variation in ventilated subjects when measured by internal medicine residents using hand-carried ultrasound devices. Chest. 2007 May; 131(5):1301-7.
    View in: PubMed
    Score: 0.062
  9. A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction. ESC Heart Fail. 2021 10; 8(5):3495-3503.
    View in: PubMed
    Score: 0.042
  10. Peak left atrial strain as a single measure for the non-invasive assessment of left ventricular filling pressures. Int J Cardiovasc Imaging. 2019 Jan; 35(1):23-32.
    View in: PubMed
    Score: 0.034
  11. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010 May; 159(5):841-849.e1.
    View in: PubMed
    Score: 0.019
  12. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Am Heart J. 2009 Jun; 157(6):1035-41.
    View in: PubMed
    Score: 0.018
  13. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol. 2008 Jun 10; 51(23):2276-85.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.